{
  "abstract": "Introduction: Homologous Recombination Repair (HRR) genes alterations are a resistance mechanism to therapies by taxanes or Androgen Receptor Signalling inhibitors in Metastatic Castration Resistant Prostate Cancer (mCRPC). BRCA-mutated mCRPC patients are eligible to poly adenosine diphosphateribose polymerase inhibitors (PARPi). Therefore, assessing the population-specific prevalence of HRR-related genes alterations is of public healthcare importance. Methods: This retrospective, non-interventional, multicentric study was conducted across 6 reference French centers in a \\\"real-life\\\" setting. 788 paraffin-embedded mCRPC patient-samples were included and submitted to testing for BRCA1/2 in six different centers; additionally, non-BRCA HRR-related genes were investigated in two different centers. Results: Among the samples, n=602 (76.4%) were contributive for molecular testing. In multivariate analysis by logistic regression and sensitivity analysis, only sample age (P<0.01), sample surface area (P=0.02) and institution (P=0.018) remained statistically significant. BRCA alterations were detected in n=39/602 (6.5%) of contributive samples, with n=35 and n=4 alterations of BRCA2 and BRCA1 respectively. Non-BRCA HRR-related genes alterations were detected in n=12/157 (7.6%) of contributive samples, with alterations of mainly ATM (n=6, 3.8%), CDK12 (n=4, 2.5%) and CHEK2 (n=2, 1.3%). Discussion: In this study, testing contributivity was similar or higher that of other studies in the literature, and observed mutations prevalences were similar to that of other screenings of western populations. Harmonising per-centres protocols and enhancing molecular testing contributivity with the screening of circulating DNA samples and expanding its range by including non-BRCA HRR-related genes in all reference centres will enable more patients to be accurately treated by targeted therapies. Level of evidence: 3 (grade C).",
  "abstract_shown": true,
  "affiliations": [],
  "article_type": null,
  "arxiv": null,
  "author_total": 15,
  "authors": [
    {
      "name": "Pierre Allaume"
    },
    {
      "name": "Maxime Raby"
    },
    {
      "name": "Maya Nourieh"
    },
    {
      "name": "Alexandra Lespagnol"
    },
    {
      "name": "Anne Tallet"
    },
    {
      "name": "Sarah Péricart"
    },
    {
      "name": "Juliet Tantot"
    },
    {
      "name": "Véronique Lindner"
    },
    {
      "name": "Myriam Decaussin-Petrucci"
    },
    {
      "name": "Celine Callens"
    },
    {
      "name": "Françoise Descôtes"
    },
    {
      "name": "Yves Allory"
    },
    {
      "name": "Nathalie Rioux-Leclercq"
    },
    {
      "name": "Solène-Florence Kammerer-Jacquet"
    },
    {
      "name": "Gaëlle Fromont-Hankard"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/fbawk14z3ye0b.bib",
  "cited_by": 0,
  "doi": "10.1016/j.fjurol.2026.103148",
  "fulltext_url": null,
  "id": "fbawk14z3ye0b",
  "issns": [
    "2950-4201",
    "2950-3930"
  ],
  "landing_url": "https://hal.science/hal-05675870v1",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "hal",
      "0.sdv"
    ],
    [
      "hal",
      "1.sdv.can"
    ],
    [
      "openalex",
      "2740|Prostate Cancer Treatment and Research"
    ]
  ],
  "openalex": "W7164917159",
  "pdf_url": "https://hal.science/hal-05675870/document",
  "pmcid": null,
  "pmid": "42303208",
  "published": "2026-10-14",
  "publisher": "Elsevier",
  "ris": "https://research.draconitic.com/paper/fbawk14z3ye0b.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:57Z",
      "native_id": "hal-05675870",
      "source": "hal",
      "url": "https://hal.science/hal-05675870v1"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "hal:0.sdv",
      "subfield": "general"
    },
    {
      "field": "medicine",
      "origin": "hal:1.sdv.can",
      "subfield": "oncology"
    }
  ],
  "title": "Prevalence of homologous recombination repair genes alterations in metastatic castration-resistant prostate cancer, a multicentric study",
  "title_text": "Prevalence of homologous recombination repair genes alterations in metastatic castration-resistant prostate cancer, a multicentric study",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:17:57Z",
  "url": "https://research.draconitic.com/paper/fbawk14z3ye0b",
  "venue": "The French Journal of Urology",
  "versions": []
}